847729-63-9

Basic information

• Product Name: (S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate
• Synonyms: (S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate
• CAS NO: 847729-63-9
• Molecular Formula: C₁₄H₁₈N₂O₂
• Molecular Weight: 246.30492
• Mol File: 847729-63-9.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 394.1±35.0 °C(Predicted)
• Appearance: /
• Density: 1.08±0.1 g/cm3(Predicted)
• PKA: 11.83±0.46(Predicted)
• CAS DataBase Reference: (S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate(847729-63-9)
• EPA Substance Registry System: (S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate(847729-63-9)

Safety Data

• Hazardous Substances Data: 847729-63-9(Hazardous Substances Data)

Usage

Description

(S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate, with the molecular formula C16H22N2O2, is a chemical compound that serves as a chiral auxiliary in organic synthesis. It is a white solid that is sparingly soluble in water. (S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate is recognized for its role in asymmetric synthesis, where it introduces chirality into molecules, and for its function as a protecting group for alcohols, amines, and carboxylic acids, enabling selective reactions in complex synthesis pathways. Furthermore, (S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate has garnered interest for its potential pharmaceutical applications due to its unique chiral properties and its influence on the stereochemistry of organic reactions.

Uses

Used in Organic Synthesis:
(S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate is used as a chiral auxiliary for introducing chirality into molecules, which is crucial for the development of enantiomerically pure compounds. This application is particularly important in the pharmaceutical industry, where the stereochemistry of a drug can significantly impact its efficacy and safety.
Used in Asymmetric Synthesis:
In the field of asymmetric synthesis, (S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate is utilized as a reagent to facilitate the creation of chiral centers in target molecules. (S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate's ability to induce chirality is valuable for producing enantiomerically enriched products, which are essential in various chemical and pharmaceutical applications.
Used as a Protecting Group:
(S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate is used as a protecting group for alcohols, amines, and carboxylic acids during complex synthesis pathways. This function allows chemists to carry out selective reactions without affecting the protected functional groups, which can then be deprotected when needed, providing a strategic advantage in multi-step synthesis processes.
Used in Pharmaceutical Applications:
(S)-tert-butyl 1-(4-cyanophenyl)ethylcarbaMate has been studied for its potential use in the pharmaceutical industry, capitalizing on its unique chiral properties. Its ability to influence the stereochemistry of organic reactions can lead to the development of new drugs with improved efficacy and selectivity, ultimately benefiting patients and advancing medical treatments.

Upstream product

• 847728-89-6 (S)-tert-butyl (1-(4-bromophenyl)ethyl)carbamate 
• 557-21-1 dicyanozinc 
• 773837-37-9 sodium cyanide 
• 1313367-04-2 [(S)-1-(4-Iodo-phenyl)-ethyl]-carbamic acid tert-butyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 557-21-1 zinc(II) cyanide 

Downstream Products

• 847729-64-0 tert-butyl [(1S)-1-(4-(2H-tetrazol-5-yl)phenyl)ethyl]carbamate 
• 916211-64-8 (S)-4-(1-aminoethyl)benzoic acid hydrochloride salt 
• 1097196-64-9 tert-butyl [(1S)-1-{4-[amino(hydroxyimino)methyl]phenyl}ethyl]carbamate 
• 36244-70-9 (S)-4-(1-aminoethyl)benzonitrile 
• 847729-65-1 [(1S)-1-(4-(2H-tetrazol-5-yl)phenyl)ethyl]amine hydrochloride 
• 1177316-44-7 (S)-4-(1-aminoethyl)benzonitrile hydrochloride 
• 1177316-44-7 (S)-4-(1-aminoethyl)benzonitrile hydrochloride 

Relevant articles and documents

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

The present disclosure relates to bifunctional compounds, which find utility as modulators of SMARCA2 or BRM (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a ligand that binds to the Von Hippel-Lindau E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

METALLOPROTEASE INHIBITORS

The present invention relates to amide containing aromatic MMP inhibiting compounds with a mono-amide heteroaromatic group, of formulas I and II:

Substituted bis-amide metalloprotease inhibitors

This invention relates to substituted bis-amide pyrimidine compounds of Formula (I), which are useful for the treatment of metalloprotease mediated diseases, in particular MMP-13 related diseases.